Aspirin use and potential mechanisms for colorectal cancer prevention.
作者信息
Williams C S, Smalley W, DuBois R N
机构信息
Department of Cell Biology, Vanderbilt University Medical Center, Nashville, Tennessee 37232-2279, USA.
出版信息
J Clin Invest. 1997 Sep 15;100(6):1325-9. doi: 10.1172/JCI119651.
Abstract
摘要
相似文献
1
Aspirin use and potential mechanisms for colorectal cancer prevention.
J Clin Invest. 1997 Sep 15;100(6):1325-9. doi: 10.1172/JCI119651.
2
Aspirin and the prevention of colorectal cancer.
N Engl J Med. 2003 Jun 12;348(24):2466-7; author reply 2466-7.
3
[Colorectal cancer and inhibition of cyclooxygenase-2].
Dtsch Med Wochenschr. 2002 Jun 7;127(23):1256-8. doi: 10.1055/s-2002-32104.
4
Cyclooxygenase inhibition in cancer--a blind alley or a new therapeutic reality?
N Engl J Med. 2002 Apr 4;346(14):1085-7. doi: 10.1056/NEJM200204043461412.
5
Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.
Nat Rev Cancer. 2001 Oct;1(1):11-21. doi: 10.1038/35094017.
6
The prevention of colorectal cancer by aspirin use.
Biomed Pharmacother. 1999 Aug;53(7):303-8. doi: 10.1016/S0753-3322(00)88500-5.
7
Use of NSAIDs for the chemoprevention of colorectal cancer.
Ann Pharmacother. 2003 Nov;37(11):1664-74. doi: 10.1345/aph.1C489.
8
9
[Cyclooxygenase 2 inhibitors and adenomatous polyposis coli].
Bull Cancer. 2004 May;91 Spec No:S85-8.
10
[Prevention of colorectal cancer: acetylsalicyclic acid and cyclo-oxygenase-2 inhibitors are only partially effective].
Ned Tijdschr Geneeskd. 2003 Nov 8;147(45):2203-7.
引用本文的文献
1
Should I take aspirin? A qualitative study on the implementation of a decision aid on taking aspirin for bowel cancer prevention.
Fam Med Community Health. 2023 Nov 30;11(Suppl 1):e002423. doi: 10.1136/fmch-2023-002423.
2
Wnt/β-Catenin Pathway-Regulated Fibromodulin Expression Is Crucial for Breast Cancer Metastasis and Inhibited by Aspirin.
Front Pharmacol. 2019 Nov 25;10:1308. doi: 10.3389/fphar.2019.01308. eCollection 2019.
3
Differences in risk factor-colorectal adenoma associations according to non-steroidal anti-inflammatory drug use.
Eur J Gastroenterol Hepatol. 2018 Nov;30(11):1318-1326. doi: 10.1097/MEG.0000000000001252.
4
Evaluation of Cytotoxicity Effects of Chalcone Epoxide Analogues as a Selective COX-II Inhibitor in the Human Liver Carcinoma Cell Line.
J Pharmacopuncture. 2017 Sep;20(3):207-212. doi: 10.3831/KPI.2017.20.024. Epub 2017 Sep 30.
5
Aspirin Prevention of Colorectal Cancer: Focus on NF-κB Signalling and the Nucleolus.
Biomedicines. 2017 Jul 18;5(3):43. doi: 10.3390/biomedicines5030043.
6
Genetic Alterations in Gastric Cancer Associated with Infection.
Front Med (Lausanne). 2017 May 2;4:47. doi: 10.3389/fmed.2017.00047. eCollection 2017.
7
Cyclooxygenase-2: A Role in Cancer Stem Cell Survival and Repopulation of Cancer Cells during Therapy.
Stem Cells Int. 2016;2016:2048731. doi: 10.1155/2016/2048731. Epub 2016 Nov 1.
8
Medical Application of Spirulina platensis Derived C-Phycocyanin.
Evid Based Complement Alternat Med. 2016;2016:7803846. doi: 10.1155/2016/7803846. Epub 2016 May 11.
9
Role of Helicobacter pylori in gastric cancer: Updates.
World J Gastrointest Oncol. 2016 Feb 15;8(2):147-58. doi: 10.4251/wjgo.v8.i2.147.
10
Paclitaxel combined with harmine inhibits the migration and invasion of gastric cancer cells through downregulation of cyclooxygenase-2 expression.
Oncol Lett. 2015 Sep;10(3):1649-1654. doi: 10.3892/ol.2015.3425. Epub 2015 Jun 25.
本文引用的文献
1
The risks and costs of upper gastrointestinal disease attributable to NSAIDs.
Gastroenterol Clin North Am. 1996 Jun;25(2):373-96. doi: 10.1016/s0889-8553(05)70253-3.
2
NSAIDs, gastrointestinal injury, and cytoprotection.
Gastroenterol Clin North Am. 1996 Jun;25(2):279-98. doi: 10.1016/s0889-8553(05)70247-8.
3
Colorectal cancer and nonsteroidal anti-inflammatory drugs.
Adv Pharmacol. 1997;39:1-20. doi: 10.1016/s1054-3589(08)60067-8.
4
Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.
J Clin Invest. 1997 May 1;99(9):2254-9. doi: 10.1172/JCI119400.
5
Cyclooxygenase, NSAIDs, and colorectal cancer.
J Gastroenterol. 1996 Dec;31(6):898-906. doi: 10.1007/BF02358623.
6
Sulfone metabolite of sulindac inhibits mammary carcinogenesis.
Cancer Res. 1997 Jan 15;57(2):267-71.
7
Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).
Cell. 1996 Nov 29;87(5):803-9. doi: 10.1016/s0092-8674(00)81988-1.
8
Elevated cyclooxygenase-2 levels in Min mouse adenomas.
Gastroenterology. 1996 Oct;111(4):1134-40. doi: 10.1016/s0016-5085(96)70083-5.
9
Chemoprevention of colon cancer by minor dietary constituents and their synthetic analogues.
Prev Med. 1996 Jan-Feb;25(1):48-50. doi: 10.1006/pmed.1996.0017.
10
Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway.
Biochem Pharmacol. 1996 Jul 26;52(2):237-45. doi: 10.1016/0006-2952(96)00181-5.
Zotero 插件